What is Cardiomatics?
Cardiomatics operates at the intersection of artificial intelligence and cardiac diagnostics, offering a sophisticated cloud-based platform designed for the analysis of electrocardiogram (ECG) signals. The company's proprietary algorithms process raw ECG data to generate comprehensive and actionable insights, aiming to streamline diagnostic processes for healthcare providers. This focus on AI-driven medical analysis places Cardiomatics within the rapidly growing health technology market, where precision and efficiency are paramount.
How much funding has Cardiomatics raised?
Cardiomatics has raised a total of $4.1M across 2 funding rounds:
Grant
$1M
Angel/Seed
$3.1M
Grant (2021): $1M with participation from Polish National Centre of Research and Development
Angel/Seed (2021): $3.1M led by Innovation Nest, Nova Capital, VC Kaya, and Nina Capital
Key Investors in Cardiomatics
Polish National Centre of Research and Development
The Polish National Centre of Research and Development is a governmental agency that supports scientific research and development activities in Poland, often funding innovative projects with commercial potential.
Innovation Nest
Innovation Nest is a venture capital firm that invests in early-stage B2B SaaS startups from Europe, assisting them in global expansion through their network and expertise.
Nina Capital
Nina Capital is a specialized venture capital firm focused on investing in health technology companies at the pre-seed and seed stages, providing capital to founders aiming to transform healthcare through information technology.
What's next for Cardiomatics?
With its recent major strategic investment, Cardiomatics is poised to accelerate its product development and market penetration. The company's enterprise-level funding context suggests a strategic push towards scaling its operations, enhancing its AI capabilities, and expanding its reach within the global healthcare ecosystem. Future growth will likely involve further integration of its analytical tools into clinical workflows and potential partnerships to broaden its impact on cardiac care.
See full Cardiomatics company page
